Jefferies lowers CenterPoint Energy stock price target on financing view By Investing.com

Jefferies trimmed its CenterPoint Energy price target to $48 from $49 but kept a Buy rating, with the stock at $42.13 implying roughly 14% upside to the new target. The company's Q1 2026 EPS was $0.56 versus $0.57 expected, while revenue beat at $2.95 billion versus $2.9 billion and full-year guidance was reiterated. Analyst commentary highlighted Houston demand charge tailwinds, Indiana growth optionality, and de-risked financing that could support about $1 billion of capex without additional equity.

Analysis

The market is treating CNP less like a regulated utility and more like an incremental infrastructure compounder, which matters because the multiple should start to reflect project optionality rather than just rate-base growth. The key second-order effect is that large-load demand charges can monetize existing system capacity faster than the balance sheet is forced to absorb full upfront capex, improving near-term FCF and reducing dilution risk. That combination is usually worth more than the headline earnings beat/miss because it compresses the payback period on new projects and lowers the probability of adverse equity issuance.

The next catalyst path is asymmetric: the stock likely rerates on project visibility over the next 3-9 months, not on quarterly EPS prints. Indiana and the transmission refresh create a “serial optionality” setup where each new study or customer commitment can extend the growth runway, but the trade is vulnerable if load growth is delayed or if regulators push back on recovery timing. The biggest hidden risk is not operating execution; it is that the market may already be underwriting a cleaner capex-to-earnings conversion than regulators ultimately allow.

Consensus appears to be underestimating the value of financing de-risking. If internal funding is sufficient for the next tranche of capex, the equity story shifts from “can they fund growth?” to “how much of the growth gets capitalized into ROE and duration?” That typically supports multiple expansion, but only until investors start asking whether incremental growth is actually lower-return than the market is assuming. In that sense, the stock is attractive as long as project economics remain visible and capital discipline is preserved; it becomes a trap if management chases scale before confirming cost recovery.

Key Decisions for Investors

• Go long CNP on pullbacks below the current trading range with a 3-6 month horizon; target a re-rating toward the low- to mid-50s if project optionality is validated, with downside contained by regulated cash flow visibility.
• Buy CNP Jan-2027 calls or call spreads to express upside from the 2H26 study refresh and incremental project awards; this is a cleaner way to own the catalyst than common if volatility stays subdued.
• Pair trade: long CNP / short a slower-growth utility with less load-driven optionality over the next 6-12 months; the relative trade should work if investors keep paying for infrastructure growth embedded in rate base.
• Add a risk trigger: if regulatory commentary suggests delayed cost recovery or slower capex pass-through, reduce exposure quickly; that would impair the multiple before the earnings impact shows up.
• Do not chase after one strong guidance reiteration; wait for confirmation from either Indiana load commitments or the transmission refresh, since those are the actual re-rating events.